Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia

BACKGROUND: SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested to contrast the hyperinflammatory process involved in the pathogenesis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchese, Valentina, Crosato, Verena, Gulletta, Maurizio, Castelnuovo, Filippo, Cristini, Graziella, Matteelli, Alberto, Castelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481762/
https://www.ncbi.nlm.nih.gov/pubmed/32910321
http://dx.doi.org/10.1007/s15010-020-01522-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481762/
https://www.ncbi.nlm.nih.gov/pubmed/32910321
http://dx.doi.org/10.1007/s15010-020-01522-4

Ejemplares similares